Nirvana Biosys Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 9.64 Cr
as on 15-11-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.85 Cr
as on 15-11-2024
- Revenue 441.58%
(FY 2023)
- Profit 92051.55%
(FY 2023)
- Ebitda -74.91%
(FY 2023)
- Net Worth 0.26%
(FY 2023)
- Total Assets 0.24%
(FY 2023)
About Nirvana Biosys
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.64 Cr.
The company currently has active open charges totaling ₹12.85 Cr.
Rachit Garg and Peeyush Aggarwal serve as directors at the Company.
- CIN/LLPIN
U15520DL2008PTC183454
- Company No.
183454
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nirvana Biosys?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rachit Garg  | Director | 12-Jun-2019 | Current |
| Peeyush Aggarwal | Director | 30-Sep-2013 | Current |
Financial Performance and Corporate Structure Insights of Nirvana Biosys.
Nirvana Biosys Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 441.58% increase. The company also saw a substantial improvement in profitability, with a 92051.55% increase in profit. The company's net worth moved up by a moderate rise of 0.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirvana Biosys?
In 2022, Nirvana Biosys had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Onus Plantations And Agro LimitedActive 16 years 4 monthsRachit Garg and Peeyush Aggarwal are mutual person
- Mps Informatics Private LimitedActive 36 years 11 months
Rachit Garg and Peeyush Aggarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Technology Development Board Creation Date: 05 Mar 2010 | ₹4.80 Cr | Open |
United Bank Of India Creation Date: 24 Jun 2009 | ₹8.05 Cr | Open |
How Many Employees Work at Nirvana Biosys?
Unlock and access historical data on people associated with Nirvana Biosys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirvana Biosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirvana Biosys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
